Cited by 355Nitric Oxide and Endothelin EffectsCancer-related gene regulationCardiovascular Health and Disease Prevention

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

Open access

Böger, Rainer H., Sullivan, Lisa M., Schwedhelm, Edzard, Wang, Thomas J., Maas, Renke, Benjamin, Emelia J., Schulze, Friedrich, Xanthakis, Vanessa, Benndorf, Ralf A., Vasan, Ramachandran S.·2009·Circulation

DOI 10.1161/circulationaha.108.838268PMC PMC2742491

Open this paper in CoChat — free account

Abstract

Background— Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, induces endothelial dysfunction. Although elevated ADMA has been associated with an increased risk of cardiovascular disease events and death in referral samples, the prognostic significance of ADMA in the community has not been adequately evaluated. Methods and Results— We related plasma ADMA, l -arginine (Arg), and the ratio of Arg to ADMA to the incidence of cardiovascular disease (fatal or nonfatal myocardial infarction, coronary insufficiency, angina pectoris, stroke or transient ischemic attack, intermittent claudication, or heart failure) and death in 3320 Framingham Offspring Study participants (1769 women; mean age, 59 years). Over a follow-up period of 10.9 years, 281 individuals of 2956 free of cardiovascular disease at baseline developed incident cardiovascular disease, and 285 participants died. In multivariable models adjusting for established risk factors and other biomarkers (B-type natriuretic peptide, renin, homocysteine, urine albumin excretion, and C-reactive protein), ADMA and the ratio of Arg to ADMA were significantly associated with all-cause mortality (adjusted-hazard ratio [HR] per 1-SD increment, 1.21; 95% CI, 1.07 to 1.37; and HR per 1-SD increment, 0.80; 95% CI, 0.69 to 0.93, respectively), whereas Arg was not (HR per 1-SD increment, 0.89; 95% CI, 0.77 to 1.02). We noted effect modification by diabetes status; ADMA was associated with death in individuals without diabetes (adjusted HR per 1-SD increment, 1.30; 95% CI, 1.13 to 1.50) but not in individuals with diabetes (adjusted HR per 1-SD increment, 0.85; 95% CI, 0.62 to 1.16). ADMA, Arg, and the ratio of Arg to ADMA were not associated with cardiovascular disease incidence ( P >0.10). Conclusions— In our large community-based sample, ADMA was significantly associated with all-cause mortality, particularly in nondiabetic individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.108.838268

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease
Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,589
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation
Palmer, R. M. J., Rees, D. D., Ashton, D. S., & Moncada, S. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81362-7 · Cited by 1,348
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P. N., Larson, M. G., Tofler, G. H., Levy, D. A., Newton‐Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,337
Self-citation
Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction: Its Role in Hypercholesterolemia
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase
Achan, V., Broadhead, M., Malaki, M., Whitley, G. S. J., LEIPER, J. M., MacAllister, R. J., & Vallance, P. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000081742.92006.59 · Cited by 593

Flagged first, then by citations

Show all 41 references

1 of the 41 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

10.1161/res.87.2.99 · DOI
10.1161/circ.98.18.1842 · DOI
10.1161/circ.101.16.1899 · DOI
10.1161/res.77.3.510 · DOI

Sorted by citations

Items 201–300 of 355

Asymmetric dimethylarginine is related to the predicted stroke risk in middle-aged Japanese men
Nishiyama, Y., Otsuka, T., Ueda, M., Inagaki, H., Muraga, K., Abe, A., Kawada, T., & Katayama, Y. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.12.021 · Cited by 13
Associations between asymmetric dimethylarginine, homocysteine, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in rheumatoid arthritis
Dimitroulas, T., Sandoo, A., Hodson, J. A., Smith, J., Douglas, K., & Kitas, G. D. (2015) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2015.1086433 · Cited by 14
L-Arginine Derivatives Are Associated with the Hyperthyroid State in the General Population
Ittermann, T., Bahls, M., Atzler, D., Friedrich, N., Schwedhelm, E., Böger, R. H., Felix, S. B., Völzke, H., & Dörr, M. (2015) · Thyroid · doi:10.1089/thy.2015.0385 · Cited by 13
Self-citation
Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris
Borgeraas, H., Hertel, J. K., Svingen, G. F. T., Pedersen, E. R., Seifert, R., Nygard, O. K., & Hjelmesaeth, J. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152029 · Cited by 13
Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia
Maďarič, J., Valachovičová, M., Paulis, L., Príbojová, J., Mateova, R., Šebeková, K., Postulková, Ľ., Madaricova, T., Bucová, M., Mistrík, M., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0622-2 · Cited by 13
Development of a novel UHPLC-MS/MS-based platform to quantify amines, amino acids and methylarginines for applications in human disease phenotyping
Ahmetaj‐Shala, B., Olanipekun, M. T., Tesfai, A., MacCallum, N. S., Kirkby, N. S., Quinlan, G. J., Shih, C., Kawai, R., Mumby, S. E., Paul‐Clark, M. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31055-8 · Cited by 13
The role of laser Doppler flowmetry tests, serum angiopoietin-2, asymmetric and symmetric dimethylarginine to predict outcome in chronic kidney disease
Nemcsik, J., Cseprekál, O., Egresits, J., Kielstein, J. T., Kümpers, P., Lukasz, A. H., Tabák, Á. G., Marton, A., Németh, Z., Járai, Z., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001256 · Cited by 14
Asymmetric dimethylarginine: An crucial regulator in tissue fibrosis
Zhao, W.-C., Li, G., Huang, C., & Jiang, J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.055 · Cited by 11
Increased levels of symmetric dimethyl-arginine are associated with all-cause mortality in patients with symptomatic peripheral arterial disease
Staniszewska, A., Rajagopalan, S., Al-Shaheen, A., Thiès, F., & Brittenden, J. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2015.01.002 · Cited by 12
Real-time functional characterization of cationic amino acid transporters using a new FRET sensor
Vanoaica, L., Behera, A. K., Camargo, S. M. R., Forster, I. C., & Verrey, F. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-015-1754-9 · Cited by 12
The Value of Circulating Biomarkers in Bicuspid Aortic Valve-Associated Aortopathy
Naito, S., Hillebrand, M., Bernhardt, A. M. J., Jagodzinski, A., Conradi, L., Detter, C., Sydow, K., Reichenspurner, H. C., Kodolitsch, Y. V., & Girdauskas, E. (2016) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-0036-1583525 · Cited by 12
Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: Cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
Zelzer, S., Enko, D., Pilz, S., Tomaschitz, A., März, W., & Meinitzer, A. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.03.013 · Cited by 12
Plasmatic Concentrations of ADMA and Homocystein in Llama (Lama glama) and Regulation of Arginase Type II: An Animal Resistent to the Development of Pulmonary Hypertension Induced by Hypoxia
López, V., Moraga, F. A., Llanos, A. J., Ebensperger, G., Taborda, M. I., & Uribe, E. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00606 · Cited by 12
Amniotic Fluid Arginine from Gestational Weeks 13 to 15 Is a Predictor of Birth Weight, Length, and Head Circumference
Jenssen, A. B., Ueland, P. M., & Bjørke‐Monsen, A. (2017) · Nutrients · doi:10.3390/nu9121357 · Cited by 11
Prognostic Value of Asymmetric Dimethylarginine in Patients with Heart Failure: A Systematic Review and Meta‐analysis
Pan, W., Lian, B., Lu, H., Liao, P., Guo, L., & Zhang, M. (2020) · BioMed Research International · doi:10.1155/2020/6960107 · Cited by 11
Dimethylarginine Dimethylaminohydrolase1 Is an Organ-Specific Mediator of End Organ Damage in a Murine Model of Hypertension
Sydow, K., Schmitz, C., von Leitner, E.-C., von Leitner, R., Klinke, A., Atzler, D., Krebs, C. F., Wieboldt, H., Ehmke, H., Schwedhelm, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048150 · Cited by 11
Self-citation
Association Between Serum Levels of Carotenoids and Serum Asymmetric Dimethylarginine Levels in Japanese Subjects
理佳, 度., Suzuki, K. A. O., Ichino, N., Osakabe, K., Sugimoto, K., Yamada, H., Hamajima, T., Hamajima, N., & Inoue, T. (2014) · Journal of Epidemiology · doi:10.2188/jea.je20130137 · Cited by 11
Removal of asymmetric dimethylarginine during artificial liver support using fractionated plasma separation and adsorption
Rifai, K., Bode‐Böger, S. M., Martens‐Lobenhoffer, J., Ernst, T., Kretschmer, U., Hafer, C., Fliser, D., Manns, M. P., & Kielstein, J. T. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.485322 · Cited by 11
Proton Pump Inhibitors and Myocardial Infarction
Freedberg, D. E., Yang, Y., & Abrams, J. A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.002 · Cited by 11
l-arginine, asymmetric and symmetric dimethylarginine for early outcome prediction in unselected cardiac arrest victims: a prospective cohort study
Csiszár, B., Márton, Z., Riba, J., Csécsei, P., Nagy, L., Tóth, K., Halmosi, R., Sándor, B., Kenyeres, P., & Molnár, T. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02767-z · Cited by 10
Esomeprazole covalently interacts with the cardiovascular enzyme dimethylarginine dimethylaminohydrolase: Insights into the cardiovascular risk of proton pump inhibitors
Smith, C. A., Ebrahimpour, A., Novikova, L., Farina, D., Bailey, A. O., Russell, W. K., Jain, A., Saltzman, A. B., Malovannaya, A., Prasad, B. V. V., et al. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130149 · Cited by 10
Asymmetric Dimethylarginine as a Biomarker in Coronary Artery Disease
Παπαγεωργίου, Ν., Theofilis, P., Oikonomou, E. K., Lazaros, G. A., Sagris, Μ., & Tousoulis, D. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221213085917 · Cited by 10
Apparently “low” serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes
Onat, A., Köroğlu, B., Can, G., Karagöz, A., Yüksel, M., & Aydın, M. (2013) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2013.5009 · Cited by 10
Apigenin ameliorates vascular injury in rats with high fructose-induced metabolic disturbance by inhibiting PI3K/AKT/GLUT1
Chen, X., Tan, J., Zhang, L., Liu, Y., Cheng, Y., Zhang, Q., & Ding, H. (2018) · RSC Advances · doi:10.1039/c8ra04459g · Cited by 10
Endothelial Dysfunction May Link Interatrial Septal Abnormalities and MTHFR-Inherited Defects to Cryptogenic Stroke Predisposition
Sgarra, L., Bortone, A. S., Potenza, M. A., Nacci, C., Salvia, M. A. D., Acquaviva, T., CILLIS, E. D., Ciccone, M. M., Grimaldi, M., & Montagnani, M. (2020) · Biomolecules · doi:10.3390/biom10060861 · Cited by 10
Sequence Variation in the DDAH1 Gene Predisposes for Delayed Cerebral Ischemia in Subarachnoidal Hemorrhage
Hannemann, J., Appel, D., Seeberger-Steinmeister, M., Brüning, T., Zummack, J., & Böger, R. H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123900 · Cited by 9
Vascular nitrosative stress in hypertension induced by fetal undernutrition in rats
Rodríguez‐Rodríguez, P., Poasakate, A., Ruvira, S., Gutiérrez-Arzápalo, P. Y., Böger, R. H., Hannemann, J., Lüneburg, N., & Arribas, S. M. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00949-1 · Cited by 9
High ADMA Is Associated with Worse Health Profile in Heart Failure Patients Hospitalized for Episodes of Acute Decompensation
Vîlcea, A., Borta, S. M., Popețiu, R. O., Rus, L. A., Pilat, L., Nica, D. V., & Pușchiță, M. (2024) · Medicina · doi:10.3390/medicina60050813 · Cited by 10
Assessment of serum asymmetric dimethylarginine levels and left ventricular diastolic function in patients with ankylosing spondylitis
İnci, Ü., Yıldız, A., Batmaz, İ., & Tekbaş, E. (2015) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12608 · Cited by 9
Monitoring of L-Arginine and Endogenous Dimethylarginines in Survivor Septic Patients - A Pilot Study.
Németh, B., Kiss, I., PÉTER, I. A., Ajtay, Z., Németh, Á., Márk, L., Csorba, A., Kőszegi, T., Mühl, D., & Kustán, P. (2016) · PubMed · Cited by 9
AGXT2 rs37369 polymorphism predicts the renal function in patients with chronic heart failure
Hu, X.-L., Zeng, W., Li, M.-P., Yang, Y., Kuang, D., Li, H., Zhang, Y.-J., Jiang, C., Peng, L., Qi, H., et al. (2017) · Gene · doi:10.1016/j.gene.2017.09.038 · Cited by 9
Ventricular arrhythmias in mouse models of diabetic kidney disease
Laurita, K. R., Khan, S., McMahon, T., Dennis, A. T., Li, V., Gaivin, R., Sapa, H., Fu, J.-D., & Schelling, J. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-99891-9 · Cited by 8
Asymmetric dimethylarginine impairs fibrinolytic activity in human umbilical vein endothelial cells via p38 MAPK and NF-κB pathways
Zhang, Q., Chen, N., Qiu, W., Xu, X., Wang, D., Tsao, P. S., & Jin, H. H. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.02.013 · Cited by 8
Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol
Oliva-Dámaso, E., Oliva-Dámaso, N., Rodríguez‐Esparragón, F., Payán, J., Marañes, A., López, Y. P., Baamonde-Laborda, L. E., Díaz, N. V., & Rodríguez-Pérez, J. C. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.10.002 · Cited by 8
Nitric Oxide, Its Role in Diabetes Mellitus and Methods to Improve Endothelial Function
Nikolaeva, M., & Johnstone, M. T. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_7 · Cited by 9
The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
Sozio, E., Hannemann, J., Fabris, M., Cifù, A., Ripoli, A., Sbrana, F., Cescutti, D., Vetrugno, L., Fapranzi, S., Bassi, F., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-36954-z · Cited by 8
Symmetric Dimethylarginine Predicts Previously Undetected Atrial Fibrillation in Patients With Ischemic Stroke
Hannemann, J., Wasser, K., Mileva, Y., Kleinsang, F., Schubert, M., Schwedhelm, E., Guan, K., Wachter, R., & Böger, R. H. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034994 · Cited by 8
Self-citation
The Markers of Endothelial Activation
Drenjančević, I., Jukić, I., Stupin, A., Ćosić, A., Stupin, M., & Selthofer-Relatić, K. (2018) · InTech eBooks · doi:10.5772/intechopen.74671 · Cited by 8
Establishment of reference values for the lysine acetylation marker Nɛ-acetyllysine in small volume human plasma samples by a multi-target LC–MS/MS method
Gessner, A., Mieth, M., Auge, D., Chafai, A., Müller, F., Fromm, M. F., & Maas, R. (2019) · Amino Acids · doi:10.1007/s00726-019-02765-8 · Cited by 8
Self-citation
Association of Variability in the DDAH1, DDAH2, AGXT2 and PRMT1 Genes with Circulating ADMA Concentration in Human Whole Blood
Hannemann, J., Zummack, J., Hillig, J., Rendant-Gantzberg, L., & Böger, R. H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040941 · Cited by 8
The interplay between exposure to PAHs and MTHFR C677T polymorphism on cardiovascular risk biomarkers in Mexican women
Fernández-Macías, J. C., Ochoa‐Martínez, Á. C., Pérez-López, A. A., Pérez-López, A. L., Neri-Maldonado, I., Piña-López, I. G., & Pérez‐Maldonado, I. N. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-19245-4 · Cited by 8
Elevated plasma levels of asymmetric dimethylarginine and the risk for arrhythmic death in ischemic and non-ischemic, dilated cardiomyopathy – A prospective, controlled long-term study
Burger, A. L., Stojković, S., Diedrich, A., Demyanets, S., Wojta, J., & Pezawas, T. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.05.016 · Cited by 8
L-arginine dependence of breast cancer – molecular subtypes matter.
Hannemann, J., Oliveira‐Ferrer, L., Goele, A. K., Mileva, Y., Kleinsang, F., Röglin, A., Witzel, I., Müller, V., & Böger, R. H. (2025) · BMC Cancer · doi:10.1186/s12885-025-13908-4 · Cited by 7
Biomarkers of the L-Arginine/Dimethylarginine/Nitric Oxide Pathway in People with Chronic Airflow Obstruction and Obstructive Sleep Apnoea
Hannemann, J., Thorarinsdottir, E. H., Amaral, A. F. S., Schwedhelm, E., Schmidt-Hutten, L., Stang, H., Benediktsdóttir, B., Gunnarsdóttir, I., Gíslason, Þ., & Böger, R. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165230 · Cited by 7
Self-citation
ADMA and NT pro‐ BNP are associated with overall mortality in elderly
Rezaei, S. S., Weisshaar, S., Litschauer, B., Gouya, G., Ohrenberger, G., & Wolzt, M. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13041 · Cited by 7
Screening of commonly prescribed drugs for effects on the CAT1-mediated transport of l-arginine and arginine derivatives
Banjarnahor, S. D. S., König, J., & Maas, R. (2022) · Amino Acids · doi:10.1007/s00726-022-03156-2 · Cited by 7
Self-citation
Elevated circulating asymmetric dimethylarginine levels in rheumatoid arthritis: a systematic review and meta-analysis
Zhao, C., Wu, Q., Mao, Y., Liu, L., Dan, Y., Li, X., Wang, D., & Pan, H. (2019) · Amino Acids · doi:10.1007/s00726-019-02714-5 · Cited by 7
Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report
Sulicka‐Grodzicka, J., Surdacki, A., Strach, M., Kwater, A., Gryglewska, B., Ćwiklińska, M., Balwierz, W. A., & Grodzicki, T. K. (2012) · Disease Markers · doi:10.1155/2012/250286 · Cited by 7
Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6‐Year Follow‐Up Study
Dimitroulas, T., Hodson, J. A., Sandoo, A., Smith, J., Douglas, K., & Kitas, G. D. (2015) · Mediators of Inflammation · doi:10.1155/2015/796562 · Cited by 6
Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of “Toxin Syndrome” in Coronary Heart Disease
Xu, H., Chen, Z., Shang, Q.-H., Gao, Z.-Y., Yu, C., Shi, D., & Chen, K. (2019) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-2701-y · Cited by 6
Metabolic Remodeling with Hepatosteatosis Induced Vascular Oxidative Stress in Hepatic ERK2 Deficiency Mice with High Fat Diets
Kujiraoka, T., Kagami, K., Kimura, T., Ishinoda, Y., Shiraishi, Y., Ido, Y., Endo, S., Satoh, Y., & Adachi, T. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158521 · Cited by 6
Endothelial biomarkers and platelet reactivity on ticagrelor versus clopidogrel in patients after acute coronary syndrome with and without concomitant type 2 diabetes: a preliminary observational study
Chyrchel, B., Kruszelnicka, O., & Surdacki, A. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01685-4 · Cited by 6
Pre-Analytical and Clinical Validation of a Dried Blood Spot Assay for Asymmetric Dimethylarginine and L-Arginine
Hannemann, J., Roskam, T. I., Eilermann, I., Siqués, P., Brito, J., & Böger, R. H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041072 · Cited by 6
Asymmetric dimethylarginine predicts perioperative cardiovascular complications in patients undergoing medium-to-high risk non-cardiac surgery
Appel, D., Böger, R. H., Windolph, J., Heinze, G., Goetz, A. E., & Hannemann, J. (2020) · Journal of International Medical Research · doi:10.1177/0300060520940450 · Cited by 6
Relationship between plasma asymmetric dimethylarginine and nitric oxide levels affects aerobic exercise training-induced reduction of arterial stiffness in middle-aged and older adults
Shimomura, M., Fujie, S. J., Sanada, K., Kajimoto, H., Hamaoka, T., & Iemitsu, M. (2021) · Physical Activity and Nutrition · doi:10.20463/pan.2021.0003 · Cited by 6
Transsulfuration Pathway Thiols and Methylated Arginines: The Hunter Community Study
Mangoni, A. A., Zinellu, A., Carru, C., Attia, J., & McEvoy, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054870 · Cited by 6
Redefining the biological and pathophysiological role of dimethylarginine dimethylaminohydrolase 2
Nair, P. C., Mangoni, A. A., & Rodionov, R. N. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.03.001 · Cited by 5
Asymmetric dimethylarginine (ADMA): Is really a biomarker for cardiovascular prognosis?
Tousoulis, D., Siasos, G., Oikonomou, E. K., Stougianos, P., Παπαγεωργίου, Ν., Papavassiliou, A. G., & Stefanadis, C. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.08.070 · Cited by 5
Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression
Zhang, P., Fassett, J. T., Zhu, G., Li, J., Hu, X., Xu, X., Chen, Y., & Bache, R. J. (2017) · Vascular Medicine · doi:10.1177/1358863x16681215 · Cited by 5
Renal Function Underpins the Cyclooxygenase-2: Asymmetric Dimethylarginine Axis in Mouse and Man
Ferreira, P., Vaja, R., Pires, M. E. L., Crescente, M., Yu, H., Nüsing, R. M., Liu, B., Zhou, Y., Yaqoob, M. M., Zhang, A., et al. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.03.014 · Cited by 5
The Asymmetric Dimethylarginine Level is Associated with the Predicted Stroke Risk in Japanese Women
Muraga, K., Nishiyama, Y., Otsuka, T., Ueda, M., Abe, A., & Katayama, Y. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.22582 · Cited by 5
Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease
Dragičević, M., Košuta, I., Kruezi, E., Lovrenčić, M. V., & Mrzljak, A. (2020) · Medicina · doi:10.3390/medicina56110622 · Cited by 5
Alterations in plasma L-arginine and methylarginines in heart failure and after heart transplantation
Lundgren, J., Sandqvist, A., Hedeland, M., Bondesson, U., Wikström, G., & Rådegran, G. (2018) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2018.1459823 · Cited by 5
Regulation | Transcriptional and Post-translational Regulation of the Dimethylarginines ADMA and SDMA and Their Impact on the L-arginine – Nitric Oxide Pathway
Hannemann, J., & Böger, R. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00128-6 · Cited by 5
Changes in the Plasma and Platelet Nitric Oxide Biotransformation Metabolites during Ischemic Stroke—A Dynamic Human LC/MS Metabolomic Study
Bladowski, M., Szahidewicz-Krupska, E., Wiśniewski, J. Ł., Fortuna, P., Chojdak-Łukasiewicz, J., Budrewicz, S. P., Fleszar, M. G., & Doroszko, A. (2022) · Antioxidants · doi:10.3390/antiox11050955 · Cited by 4
Effect of ranolazine on plasma arginine derivatives and urinary isoprostane 8-iso-PGF2α in patients with myocardial infarction in the randomized RIMINI-Trial
Schwemer, T. F., Deutscher, N., Diermann, N., Böger, R. H., Schwedhelm, E., Blankenberg, S., & Friedrich, F. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-42239-1 · Cited by 4
Self-citation
Elevated parathyroid hormone predicts high asymmetric dimethylarginine (ADMA) concentrations in obese diabetic patients
Amarasekera, A. T., Sverdlov, A. L., Horowitz, J. D., & Ngo, D. T. M. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.05.002 · Cited by 4
Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease
Parikh, R. V., Pargaonkar, V. S., Ball, R. L., Kobayashi, Y., Kimura, T., Yeung, A. C., Cooke, J. P., & Tremmel, J. A. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.07.062 · Cited by 4
Nitric Oxide: Biological Synthesis and Functions
Förstermann, U., & Li, H. (2012) · Springer eBooks · doi:10.1007/978-3-642-30338-8_1 · Cited by 4
Endothelial Dysfunction, Nitric Oxide Bioavailability, and Asymmetric Dimethyl Arginine
Zoccali, C. (2010) · Springer eBooks · doi:10.1007/978-88-470-1463-3_17 · Cited by 4
Aszimmetrikus dimetilarginin: a cardiovascularis betegségek prediktora?
Németh, B., Kustán, P., Németh, Á., Lenkey, Z., Cziráki, A., Kiss, I., Sulyok, E., & Ajtay, Z. (2016) · Orvosi Hetilap · doi:10.1556/650.2016.30396 · Cited by 4
Nitric Oxide Signaling in Depression and Antidepressant Action
Wegener, G., & Joca, S. R. L. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_45 · Cited by 4
The Endothelium
Leopold, J. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2930-6.00002-1 · Cited by 4
Reloaded: ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inaemia: effects of L-arginine and B vitamins: AUTHORS' RETROSPECTIVE
Sydow, K., & Böger, R. H. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs205 · Cited by 4
Predictive value of asymmetric dimethylarginine and C-reactive protein for the risk of developing metabolic syndrome in middle-aged men
Otsuka, T., Nishiyama, Y., Kachi, Y., Kato, K., Inagaki, H., & Kawada, T. (2014) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2014.10.001 · Cited by 3
Új szempontok a sószenzitív hypertoniák patomechanizmusában
Sulyok, E. (2019) · Orvosi Hetilap · doi:10.1556/650.2019.31308 · Cited by 3
Impact of combined elevations of homocysteine and asymmetric dimethylarginine on all-cause death ― The Tanushimaru Study
Toyomasu, K., Adachi, H., Enomoto, M., Fukami, A., Nakamura, S., Nohara, Y., Morikawa, N., Sakaue, A., Hamamura, H., Yamamoto, M., et al. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.01.011 · Cited by 3
Metabolome Profiling in the Plasma of Dogs with Idiopathic Dilated Cardiomyopathy: A Multiplatform Mass-Spectrometry-Based Approach
Rubić, I., Weidt, S. K., Burchmore, R., Kovačević, A., Kuleš, J., Eckersall, P. D., Torti, M., Jović, I., Kovačić, M., Gotić, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015182 · Cited by 3
A preliminary study on the relationship between sleep, depression and cardiovascular dysfunction in a 4 sample population
Bilbao, A.-D. V., Goldschmied, J., Jang, A., Ehrmann, D. E., Kaplish, N., Pitt, B., Arnedt, J. T., Sen, S., Dalack, G. W., & Deldin, P. J. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100814 · Cited by 3
Soluble CD14 Is Associated with Markers of Vascular Dysfunction in Bariatric Surgery Patients
Trøseid, M., Nestvold, T. K., Nielsen, E. W., Thoresen, H., Seljeflot, I., & Lappegård, K. T. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0111 · Cited by 3
Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction
Lehmann, H. I., Goette, A., Martens‐Lobenhoffer, J., Hammwöhner, M., Röhl, F. W., Bukowska, A., Ghanem, A., Klein, H. U., & Bode‐Böger, S. M. (2011) · EP Europace · doi:10.1093/europace/eur171 · Cited by 3
Asymmetric dimethylarginine (ADMA) and cardiovascular disease
Davids, M., & Teerlink, T. (2012) · Pure Amsterdam UMC · Cited by 3
Cell cycle arrest in peripheral blood mononuclear cells: A non-invasive method for diagnosis of coronary artery disease
Raj, V. S., Charles, S., Ramasamy, M., Goenka, L., Kamatchi, M., George, M., Arockiaraj, J., Dhandapani, V. E., Angayarkanni, N., & Mala, K. (2019) · Process Biochemistry · doi:10.1016/j.procbio.2019.05.027 · Cited by 3
Other Factors Ought to Be Kept in Mind When Analyzing Plasma Asymmetric Dimethylarginine Levels
Kurtoğlu, E., Balta, Ş., Karakuş, Y., & Yaşar, E. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpt275 · Cited by 3
Asymmetric dimethylarginine and citrulline are risk factors for cardiovascular disease independently of both estimated and measured GFR
Rinde, N. B., Melsom, T., Fuskevåg, O., Eriksen, B. O., & Norvik, J. V. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf181 · Cited by 2
Higher levels of SDMA and not ADMA are associated with poorer survival of trial patients with systemic ANCA-associated vasculitis
Erdbrügger, U., Kielstein, J. T., Westman, K. W. A., Ma, J. Z., Xin, W., Bode-Böger, S. M., Segelmark, M., Rasmussen, N., & de Groot, K. (2018) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2018.17119 · Cited by 2
Are proton pump inhibitors among the risk factors for acute coronary syndrome?
Alamoudi, B. M., Ibrahim, N. K., & Kalo, B. (2019) · Saudi Medical Journal · doi:10.15537/smj.2019.11.24602 · Cited by 2
Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study
Yola, I. M., Moser, C., Duncan, M. S., Schwedhelm, E., Atzler, D., Maas, R., Hannemann, J., Böger, R. H., Vasan, R. S., & Xanthakis, V. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254577 · Cited by 2
Self-citation
Diurnal Variation of L-Arginine and the Cardiovascular Risk Markers Asymmetric and Symmetric Dimethylarginine and Homoarginine in Rotating Night Shift Workers and Controls
Hannemann, J., Skene, D. J., Middleton, B., Schwedhelm, E., Laing, A., & Böger, R. H. (2023) · Biomolecules · doi:10.3390/biom13091282 · Cited by 2
Self-citation
Defining the role of exertional hypoxemia and pulmonary vasoconstriction on lung function decline, morbidity, and mortality in patients with chronic obstructive lung disease – the PROSA study: rationale and study design
Böger, R. H., & Hannemann, J. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03074-x · Cited by 3
Plasma Asymmetric Dimethylarginine in Infants with Bronchopulmonary Dysplasia: A Promising Biomarker Despite Uncertain Pathogenic Significance
Aschner, J. L., & Fike, C. D. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.10.039 · Cited by 2
Serum Methylarginines and Hearing Loss in a Population-based Cohort of Older Adults
McEvoy, M., Harris, D., Mangoni, A. A., & Sarant, J. Z. (2018) · Otology & Neurotology · doi:10.1097/mao.0000000000001716 · Cited by 2
Inibidores da bomba de protões e o risco de eventos adversos graves – uma bomba cardiovascular?
Cunha, N., & Machado, A. P. (2018) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.10.012 · Cited by 2
Proton pump inhibitors and the risk of severe adverse events – A cardiovascular bombshell?
Cunha, N., & Machado, A. P. (2018) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2017.10.014 · Cited by 2
Cardiovascular Safety in Drug Development
Ruiz-García, J., & Alegría‐Barrero, E. (2016) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416639719 · Cited by 2
Asymmetric Dimethylarginine Level as an Indicator for Cardiovascular Risk in Patients with Metabolic Syndrome
Arıcı, S., Kapuci, A., Kiyici, S. K., & Kısakol, G. (2020) · European Archives of Medical Research · doi:10.4274/eamr.galenos.2019.39200 · Cited by 1
The components of arginine and methylarginine metabolism are indicative of altered kidney function in intrauterine growth-restricted neonates
Kleinebenne, L., Röhrig, W., Ebach, F., Reutter, H. M., Pankraz, A., Heuchel, K. M., Müller, A., & Hilger, A. C. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003818 · Cited by 1
Identifying key genes in COPD risk via multiple population data integration and gene prioritization
Zainab, A., Anzawa, H., & Kinoshita, K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305803 · Cited by 2
Fibroblast Cyclo‐Oxygenase‐2 Associated With the Kidney Restrains Methylarginines and Thrombosis: Relevance to Cardiovascular Side Effects of Non‐Steroidal Anti‐Inflammatory Drugs
Pires, M. E. L., Shala, F., Soffientini, U., Cypaite, N., Vinokurova, M., Gashaw, H. H., Vaja, R., Ferreira, P., Elghazouli, Y., Vadgama, A., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202501900r · Cited by 1
Cardiotoxic effects of pantoprazole in Wistar rats submitted to cardiac ischemia and reperfusion
dos Santos, A. C., Silva, C. M. C., de Araújo, E. A., Sassi, L. D. O., Caixeta, A., Taha, M. O., Pires-Oliveira, M., Caricati-Neto, A., Lópes, R. D., Tallo, F. S., et al. (2025) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20251415 · Cited by 1

Authors: Böger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S.
Affiliations: From the Clinical Pharmacology Unit, Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (R.H.B., E.S., R.M., F.S., R.A.B.); Framingham Heart Study, Framingham, Mass (L.M.S., T.J.W., E.J.B., V.X., R.S.V.); Department of Biostatistics (L.M.S., V.X.) and Cardiology Division and Preventive Medicine (E.J.B., R.S.V.), Boston University School of Public Health, Boston, Mass; and Cardiology Division, Massachusetts General Hospital, Boston (T.J...
Boston University (US)
ORCID: Sullivan, Lisa M.
Schwedhelm, Edzard
Wang, Thomas J.
Maas, Renke
Benjamin, Emelia J.
Schulze, Friedrich
Xanthakis, Vanessa
Benndorf, Ralf A.
Vasan, Ramachandran S.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2009-03-31
Volume: 119
Issue: 12
Pages: 1592-1600
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.108.838268
PMC: PMC2742491
OpenAlex: W2136960413
Cited by: 351
References: 41
Citations by year: 2026: 2 · 2025: 8 · 2024: 11 · 2023: 13 · 2022: 17 · 2021: 10 · 2020: 20 · 2019: 15 · 2018: 21 · 2017: 21 · 2016: 24 · 2015: 33 · 2014: 29 · 2013: 21 · 2012: 29
FWCI: 23.49
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Deutsche Forschungsgemeinschaft
National Institutes of Health (5k23hl074077-03, n01hc25195-41-0-1, n01hv28178-12-0-0)
National Heart, Lung, and Blood Institute (K23 HL074077-01, 2K24 HL 04334, N01‐HC25195, K23-HL-074077, K24HL004334, N01-HC-025195, N01-HV-028178)
Topics: Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords: asymmetric dimethylarginine, L-arginine, endothelial dysfunction, nitric oxide synthase inhibition, cardiovascular disease incidence, all-cause mortality, cardiovascular mortality, diabetes mellitus, Framingham Offspring Study, community-based cohort, prognostic factors
MeSH terms: Aged, Arginine, Cardiovascular Diseases, Cause of Death, Diabetes Mellitus, Follow-Up Studies, Humans, Middle Aged, Mortality, Predictive Value of Tests, Prognosis, Incidence, Proportional Hazards Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks